(Q46134940)

English

Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study

scientific article published on 29 January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

0 references

author name string

J M Flack

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

D A Calhoun

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

L Satlin

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

M Barbier

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

R Hilkert

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

P Brunel

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

publication date

29 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

23

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

479-489

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Hypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do Better

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

The renin-angiotensin system and blood pressure: differences between blacks and whites

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Normotensive salt sensitivity: effects of race and dietary potassium

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Central role for ENaC in development of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

The renin-angiotensin system in blacks: Active, passive, or what?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Is the effect of low birth weight on cardiovascular mortality mediated through high blood pressure?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Racial disparities in hypertension prevalence, awareness, and management

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

The effect of a losartan-based treatment regimen on isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Epidemiology of hypertension and cardiovascular disease in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Impact of aortic stiffness on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Ambulatory arterial stiffness index predicts stroke in a general population

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

21 January 2018

Ethnic/racial variations in blood pressure awareness, treatment, and control

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Salt and blood pressure responses to calcium antagonism in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal treatment of hypertension and cardiovascular risk reduction in African Americans: treatment approaches for outpatients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.153

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JHH.2008.153

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19190658

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46134940&oldid=2207663851"